Submitted by Catherine Atkins on Tue, 08/07/2025 - 12:00
Dr Andreas Hadjinicolaou, NIHR Clinical Lecturer in Gastroenterology at Addenbrookes Hospital and the University of Cambridge, has been awarded this year's UK Barrett’s Oesophagus Registry (UKBOR) Prize by the British Society of Gastroenterology (BSG). This award is given annually to one exceptional, up-and-coming researcher and is open to both clinicians and scientists. This year's award recognises Dr Hadjinicolaou's contributions in original work in the field of oesophago-gastric diseases, particularly diagnosis and progression of premalignant pathologies for early detection and treatment of oesophageal and gastric cancers.
This is the second year in a row that Dr Hadjinicolaou has received national recognition by the British Society of Gastroenterology (BSG) as he was also awarded the prestigious BSG Young Gastroenterologist of the Year prize in 2024.
Dr Hadjinicolaou received his prize at this year's annual BSG Conference in Glasgow where he also gave an oral presentation on his latest work on improving the quality of upper GI endoscopy for early cancer detection. The prize comes with a certificate and engraved medal as well as an all-expenses trip to attend the USA Digestive Diseases Week in 2026 in Chicago, Illinois.
Andreas commented: “I am delighted and honoured to have received the UKBOR prize and have our work recognised by the national society of gastroenterology, one of the cardinal institutions of our specialty worldwide. Knowing that our peers see value in this work is humbling and motivational. It is a testament to our untiring efforts to improve endoscopy quality and discover biomarkers for early detection of oesophago-gastric cancers. These cancers are most often found late at advanced, non-curative stages and thus, have poor patient outcomes which we hope to change with early effective treatments. Good research is a truly collaborative effort and as such, I would particularly like to acknowledge my colleagues and mentors, that have supported and inspired me throughout the years. Above all, I am grateful to our patients; their trust and willingness to take part in research are what make everything we do possible and meaningful."